News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
107,542 Results
Type
Article (4247)
Company Profile (19)
Press Release (103276)
Section
Business (32033)
Career Advice (108)
Deals (5250)
Drug Delivery (5)
Drug Development (5401)
Employer Resources (11)
FDA (3199)
Job Trends (2077)
News (47016)
Policy (3873)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
Academia (363)
Allergies (9)
Alliances (11213)
ALS (5)
Alzheimer's disease (301)
Antibody-drug conjugate (ADC) (2)
Approvals (3207)
Artificial intelligence (76)
Automation (3)
Bankruptcy (46)
Best Places to Work (1719)
Biosimilars (6)
Biotechnology (11)
Bladder cancer (7)
Brain cancer (5)
Breast cancer (49)
Cancer (338)
Cardiovascular disease (20)
Career advice (99)
Career pathing (1)
CAR-T (9)
Cell therapy (19)
Cervical cancer (3)
Clinical research (4146)
Collaboration (146)
Compensation (14)
COVID-19 (479)
C-suite (25)
Cystic fibrosis (8)
Data (190)
Decentralized trials (1)
Depression (4)
Diabetes (16)
Diagnostics (5762)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (12)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (4)
Earnings (10388)
Employer branding (2)
Employer resources (11)
Events (13451)
Executive appointments (90)
FDA (3355)
Featured Employer (3)
Fibrodysplasia Ossificans Progressiva (1)
Funding (114)
Gene editing (1)
Generative AI (8)
Gene therapy (13)
GLP-1 (38)
Government (624)
Guidances (4)
Healthcare (2910)
IgA nephropathy (1)
Immunology and inflammation (5)
Indications (1)
Infectious disease (503)
Inflammatory bowel disease (12)
Influenza (9)
Intellectual property (4)
Interviews (12)
IPO (1793)
IRA (1)
Job creations (401)
Job search strategy (94)
Kidney cancer (4)
Labor market (1)
Layoffs (24)
Leadership (1)
Legal (534)
Liver cancer (11)
Lung cancer (36)
Lymphoma (27)
Management (3)
Manufacturing (40)
MASH (4)
Medical device (2450)
Medtech (2450)
Mergers & acquisitions (3522)
Metabolic disorders (30)
Multiple sclerosis (15)
NASH (3)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (348)
NextGen: Class of 2025 (702)
Non-profit (546)
Northern California (300)
Now hiring (2)
Obesity (10)
Opinion (11)
Ovarian cancer (12)
Pain (3)
Pancreatic cancer (7)
Parkinson's disease (13)
Partnered (3)
Patents (16)
Patient recruitment (8)
Peanut (4)
People (8925)
Pharmaceutical (1)
Phase I (1256)
Phase II (1742)
Phase III (1589)
Pipeline (92)
Podcasts (1)
Policy (1)
Postmarket research (212)
Preclinical (589)
Press Release (11)
Prostate cancer (30)
Psychedelics (1)
Radiopharmaceuticals (120)
Rare diseases (27)
Real estate (861)
Recruiting (5)
Regulatory (2993)
Reports (10)
Research institute (425)
Resumes & cover letters (15)
Schizophrenia (1)
Series A (14)
Series B (11)
Service/supplier (2)
Sickle cell disease (1)
Southern California (241)
Sponsored (5)
Startups (622)
Stomach cancer (2)
Supply chain (3)
The Weekly (1)
United States (2672)
Vaccines (35)
Venture capitalists (5)
Weight loss (4)
Women's health (5)
Date
Today (26)
Last 7 days (107)
Last 30 days (523)
Last 365 days (5165)
2025 (982)
2024 (5118)
2023 (6128)
2022 (10208)
2021 (9617)
2020 (8993)
2019 (6147)
2018 (4853)
2017 (5400)
2016 (5390)
2015 (6125)
2014 (4647)
2013 (4132)
2012 (4450)
2011 (4646)
2010 (4082)
Location
Africa (131)
Alabama (6)
Alaska (1)
Arizona (50)
Arkansas (2)
Asia (5305)
Australia (1238)
California (644)
Canada (239)
China (27)
Colorado (47)
Connecticut (57)
Delaware (4)
Europe (15092)
Florida (81)
Georgia (35)
Idaho (4)
Illinois (86)
India (4)
Indiana (27)
Iowa (3)
Japan (18)
Kansas (11)
Kentucky (4)
Louisiana (1)
Maine (20)
Maryland (85)
Massachusetts (359)
Michigan (62)
Minnesota (70)
Missouri (24)
Montana (4)
Nebraska (8)
Nevada (1)
New Hampshire (18)
New Jersey (123)
New Mexico (17)
New York (252)
North Carolina (174)
North Dakota (6)
Northern California (300)
Ohio (22)
Oklahoma (2)
Oregon (6)
Pennsylvania (72)
Rhode Island (3)
South America (153)
South Carolina (2)
Southern California (241)
Tennessee (24)
Texas (140)
Utah (71)
Virginia (34)
Washington D.C. (5)
Washington State (59)
Wisconsin (26)
107,542 Results for "provista diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Olympus Awarded PROVISTA Contract for Advanced Energy Portfolio
Olympus announced that it has been awarded a contract for its advanced energy portfolio by Provista Inc.
March 29, 2024
·
3 min read
Pharm Country
Todos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen Diagnostics
Todos Medical, Ltd. (OTCQB: TOMDF) today announced it has entered into a letter of intent with Acumen Diagnostics Pte Ltd of Singapore for its CLIA/CAP-certified clinical testing lab Provista Diagnostics to license the laboratory developed test (LDT) rights to commercialize the sepsis PCR-based diagnostic test AcuSept® in the United States.
March 28, 2023
·
7 min read
Pharm Country
Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified laboratory Provista Diagnostics has initiated a validation plan for PCR-based Avian Influenza A (H5N1, bird flu) human testing.
February 14, 2023
·
5 min read
Pharm Country
Todos Medical Initiates Validation Plan for PCR-based Polio Testing at CLIA/CAP Laboratory Provista Diagnostics
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified laboratory Provista Diagnostics has initiated a validation plan for PCR-based polio testing.
September 14, 2022
·
6 min read
Pharm Country
Todos Medical Announces Saliva-Only MonkeyPox Testing at CLIA/CAP Clinical Lab Provista Diagnostics
Todos Medical, Ltd. today announced that its Atlanta-area CLIA/CAP-certified clinical laboratory Provista Diagnostics, Inc. is now offering saliva-only MonkeyPox testing.
August 26, 2022
·
6 min read
Pharm Country
Todos Medical Announces Successful Pilot Launch of Suite of PCR Testing Services by CLIA/CAP Lab Provista Diagnostics
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP laboratory, Provista Diagnostics, has successfully completed a pilot launch of the Company’s Suite of PCR Testing services in the rural city of Dunnellon, Florida.
October 6, 2022
·
7 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Pharm Country
Todos Medical Announces PCR Validation of Wound and Respiratory Pathogen Panels at CLIA/CAP Lab Provista Diagnostics
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified laboratory Provista Diagnostics has completed validation of its PCR-based Wound and Respiratory Pathogen panels.
August 10, 2022
·
8 min read
Pharm Country
Todos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics
Todos Medical, Ltd. today announced that its CLIA/CAP-certified laboratory Provista Diagnostics has initiated a validation plan for PCR-based MonkeyPox testing.
August 3, 2022
·
5 min read
Business
Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced the appointment of Philippe Goix as Chief Commercial Officer for Todos Medical’s wholly-owned CLIA/CAP certified lab, Provista Diagnostics.
April 21, 2022
·
8 min read
1 of 10,755
Next
